BioNTech launches exchange offer for CureVac
- Location
- Mainz / Tübingen · 🇩🇪 Germany
- Sector
- Pharma
- Organisations
- BioNTech SE ↔ CureVac N.V.
- Transaction
- Acquisition
- Volume
- $1.25 billion
- Status
- completed
BioNTech is launching a public exchange offer for the full takeover of CureVac; the all-stock deal values CureVac at around $1.25 billion. Update (6 January 2026): The takeover is complete — after the exchange offer, BioNTech took over all remaining CureVac shares through a post-offer reorganisation and is now the sole owner; Nasdaq trading was suspended on 6 January 2026 and the delisting took effect on 16 January 2026 (Panabee, 6 January 2026).
Source: biontech.com ↗ · Archived copy ↗
Evidence: one source · archived copy saved · How well sourced is Eurotrack?
More from: 🇩🇪 Germany